Related Experiment Video
Updated: Mar 8, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
High-dose anti-histamine use and risk factors in children with urticaria
Pınar Uysal1, Sibelnur Avcil2, Duygu Erge1
1Division of Pediatric Allergy and Clinical Immunology, Adnan Menderes University School of Medicine, Aydın, Turkey.
Insights
Children with chronic urticaria, especially those aged 10 and older, often require higher doses of H1-antihistamines. Disease severity and low basophil counts are key risk factors for this increased need.
Area of Science:
- Pediatric Allergy and Immunology
- Dermatology
- Clinical Pharmacology
Background:
- Urticaria is a common condition in children, primarily managed with H1-antihistamines.
- Identifying factors influencing treatment response is crucial for optimizing care.
Purpose of the Study:
- To evaluate risk factors associated with the need for high-dose H1-antihistamines in pediatric urticaria.
- To analyze differences between acute and chronic urticaria in children.
Main Methods:
- Retrospective analysis of medical data from 230 children with urticaria (2014-2016).
- Recorded variables included demographics, atopic history, blood counts (eosinophils, basophils), IgE levels, and urticaria activity scores (UAS7).
- Evaluated autoimmune markers and skin prick tests in chronic urticaria cases.
Main Results:
- Chronic urticaria was more prevalent in older children (≥10 years) and associated with higher H1-antihistamine requirements.
- No significant differences in eosinophil, basophil counts, or total IgE between acute and chronic groups.
- Higher UAS7 scores and basopenia were identified as significant risk factors for requiring high-dose H1-antihistamines in chronic urticaria.
Conclusions:
- Increasing age is linked to a higher need for high-dose H1-antihistamines in pediatric urticaria.
- Disease severity (UAS7) and basopenia are significant predictors of high-dose H1-antihistamine requirement.
Aim:
The drugs of choice in the treatment of urticaria in children are H1-antihistamines. The aim of the study was to evaluate children with urticaria and define risk factors for requirement of high-dose H1-antihistamines in children with urticaria.
Material And Methods:
The medical data of children who were diagnosed as having urticaria admitted to our outpatient clinic between January 2014 and January 2016 were searched. The medical histories, concomitant atopic diseases, parental atopy histories, medications, treatment responses, blood eosinophil and basophil counts, and serum total IgE levels were recorded. In addition, the urticaria activity score for seven days, autoimmune antibody tests, and skin prick test results were evaluated in children with chronic urticaria.
Results:
The numbers of the children with acute and chronic urticaria were 138 and 92, respectively. The age of the children with chronic urticaria was higher than that of those with acute urticaria (p<0.0001). There was no difference between the two groups in terms of blood eosinophil and basophil counts, and serum total IgE levels (p>0.05). There was a negative correlation between blood eosinophil count and the UAS7 score in children with chronic urticaria (r=-0.276, p=0.011). Chronic urticaria and requirement of high dose H1-antihistamines were significant in children aged ≥10 years (p<0.001, p=0.015). High UAS7 score (OR: 1.09; CI 95%: [1.03-1.15]) and basopenia (OR: 6.77; CI 95%: [2.01-22.75]) were associated with the requirement of high-dose H1-AH in children with chronic urticaria.
Conclusion:
The requirement of high-dose H1-antihistamines was higher with children's increasing age. Disease severity and basopenia were risk factors for the requirement of high-dose H1-antihistamines.
Related Concept Videos
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Allergic Reactions
Allergic Reactions: Anaphylaxis
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drug Toxicity: Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

